Home → Resource → Mielke J, Woehling H, Jones B. Longitudinal assessment of the impact of multiple switches between a biosimilar and its reference product on efficacy parameters. Pharmaceutical Statistics. 2018;1–17. https://doi.org/10.1002/pst.1849

Mielke J, Woehling H, Jones B. Longitudinal assessment of the impact of multiple switches between a biosimilar and its reference product on efficacy parameters. Pharmaceutical Statistics. 2018;1–17. https://doi.org/10.1002/pst.1849

http://onlinelibrary.wiley.com/doi/10.1002/pst.1849/full

website

EU Funding
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 633567.
©2015 Lancaster University